The discovery of LOC729991 activators would begin with the elucidation of the properties and biological role of the encoded protein, should it exist. This would involve a combination of genomic, proteomic, and biochemical techniques to determine its expression pattern, cellular localization, and functional interactions. If the protein were to play a role in a particular cellular pathway, understanding the mechanism of action would be crucial. Structural biologists might use techniques such as X-ray crystallography or cryo-electron microscopy to resolve the protein's structure, which would reveal potential binding sites for small molecules. Such structural insights would be invaluable for the rational design of molecules that could interact with the protein and modulate its activity.
Once target sites on the protein are identified, chemical libraries could be screened for molecules that interact with those sites. Hits from these screens would represent initial activator candidates, which would then be subject to further chemical optimization. This process would involve synthesizing derivatives of the initial molecules, tweaking their chemical structures to improve their binding efficiency, selectivity for LOC729991, and cellular uptake. Such optimization is a meticulous, iterative process that relies heavily on structure-activity relationship (SAR) studies, where each modification to the molecular structure is evaluated for its impact on the interaction with LOC729991. The development of LOC729991 activators would provide important tools for probing the function of the protein and could potentially illuminate new aspects of cellular function, contributing to the basic understanding of cellular biology and expanding the compendium of molecular tools available for research.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Tretinoin, a retinoic acid receptor agonist, can modulate gene transcription and might induce the readthrough expression in specific cell types. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
PMA activates protein kinase C (PKC), which can lead to altered transcription factor activity and gene expression. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $27.00 $37.00 | 5 | |
As a beta-adrenergic agonist, isoproterenol can increase cAMP levels, potentially affecting gene transcription through the cAMP response element-binding protein (CREB). | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
Thapsigargin raises intracellular calcium levels, which can modulate calcium-sensitive signaling pathways influencing gene expression. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $57.00 $182.00 $92.00 | 21 | |
Camptothecin inhibits topoisomerase I, affecting DNA replication and transcription, which could influence readthrough transcription events. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $60.00 $270.00 $350.00 | 48 | |
AICAR activates AMPK, which can regulate transcriptional programs involved in cellular stress responses and potentially readthrough expression. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $80.00 $212.00 $408.00 | 48 | |
SB431542 is an inhibitor of the TGF-beta receptor, affecting downstream signaling and potentially altering transcriptional readthrough. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002 is a PI3K inhibitor that can alter AKT signaling and downstream transcriptional activities, possibly affecting readthrough expression. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin inhibits mTOR signaling, which could lead to changes in gene transcription and possibly influence readthrough events. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
SAHA is a histone deacetylase inhibitor that alters chromatin structure and can affect gene expression, potentially inducing readthrough. | ||||||